Endothelial dysfunction: Many ways to correct- trends that promise

Kiruga Val Ramesh, K. Ashok Shenoy

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Endothelium is considered as the largest endocrine organ of the human body. The biological functions of endothelium are numerous and may vary according to the size and distribution of the blood vessel. Endothelium serves and participates in highly active metabolic and regulatory function including control of primary hemostasis, platelet and leukocyte interaction with the vessel wall. Also, it interacts with the lipoprotein metabolism and presentation of histocompatibility antigens. These dynamic and intricate functions of endothelium are extremely vulnerable which forms the basis for many therapeutic goals to be achieved. A plethora of bioactive molecules have been produced by endothelium. Endothelial factors influence vascular tone, blood flow, clot deposition, clot lysis and selective phagocytic activity. Many protein growth factors, matrix supporting proteins and vasoactive substances have been produced by the endothelium. The functions of vascular endothelium are dynamic rather than fixed. Endothelial derived substances can be mutually antagonistic. Injury to the endothelium causes dysfunction. Immune complexes, lipids, angioplasty, germs, hypertension, shear stress, hypoxia, acidosis, smoking, aging, diabetes mellitus and surgery inflict injury to the endothelium. Endothelial dysfunction is a major cardiovascular factor implicated in the pathogenesis of atherosclerosis, arterial thrombosis, pulmonary hypertension, myocardial infarction, stroke and deep vein thrombosis. New groups of salvaging drugs have been introduced to overcome the consequences of endothelial dysfunction. Yet, the value of existing drug treatment cannot be condoned in conditions of endothelial dysfunction. Time is right to embark on the drugs that modulate endothelial functions to control morbidity and mortality in various cardiovascular diseases. Hopefully, future research will offer us better drugs.

Original languageEnglish
Pages (from-to)73-82
Number of pages10
JournalIndian Journal of Pharmacology
Volume35
Issue number2
Publication statusPublished - 01-04-2003

Fingerprint

Endothelium
Pharmaceutical Preparations
Thrombosis
Histocompatibility Antigens
Vascular Endothelium
Wounds and Injuries
Acidosis
Antigen-Antibody Complex
Hemostasis
Angioplasty
Human Body
Pulmonary Hypertension
Venous Thrombosis
Lipoproteins
Blood Vessels
Atherosclerosis
Intercellular Signaling Peptides and Proteins
Diabetes Mellitus
Proteins
Leukocytes

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

Cite this

@article{4d8c438eea4a4c42ae89d5e72640172d,
title = "Endothelial dysfunction: Many ways to correct- trends that promise",
abstract = "Endothelium is considered as the largest endocrine organ of the human body. The biological functions of endothelium are numerous and may vary according to the size and distribution of the blood vessel. Endothelium serves and participates in highly active metabolic and regulatory function including control of primary hemostasis, platelet and leukocyte interaction with the vessel wall. Also, it interacts with the lipoprotein metabolism and presentation of histocompatibility antigens. These dynamic and intricate functions of endothelium are extremely vulnerable which forms the basis for many therapeutic goals to be achieved. A plethora of bioactive molecules have been produced by endothelium. Endothelial factors influence vascular tone, blood flow, clot deposition, clot lysis and selective phagocytic activity. Many protein growth factors, matrix supporting proteins and vasoactive substances have been produced by the endothelium. The functions of vascular endothelium are dynamic rather than fixed. Endothelial derived substances can be mutually antagonistic. Injury to the endothelium causes dysfunction. Immune complexes, lipids, angioplasty, germs, hypertension, shear stress, hypoxia, acidosis, smoking, aging, diabetes mellitus and surgery inflict injury to the endothelium. Endothelial dysfunction is a major cardiovascular factor implicated in the pathogenesis of atherosclerosis, arterial thrombosis, pulmonary hypertension, myocardial infarction, stroke and deep vein thrombosis. New groups of salvaging drugs have been introduced to overcome the consequences of endothelial dysfunction. Yet, the value of existing drug treatment cannot be condoned in conditions of endothelial dysfunction. Time is right to embark on the drugs that modulate endothelial functions to control morbidity and mortality in various cardiovascular diseases. Hopefully, future research will offer us better drugs.",
author = "Ramesh, {Kiruga Val} and Shenoy, {K. Ashok}",
year = "2003",
month = "4",
day = "1",
language = "English",
volume = "35",
pages = "73--82",
journal = "Indian Journal of Pharmacology",
issn = "0253-7613",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "2",

}

Endothelial dysfunction : Many ways to correct- trends that promise. / Ramesh, Kiruga Val; Shenoy, K. Ashok.

In: Indian Journal of Pharmacology, Vol. 35, No. 2, 01.04.2003, p. 73-82.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Endothelial dysfunction

T2 - Many ways to correct- trends that promise

AU - Ramesh, Kiruga Val

AU - Shenoy, K. Ashok

PY - 2003/4/1

Y1 - 2003/4/1

N2 - Endothelium is considered as the largest endocrine organ of the human body. The biological functions of endothelium are numerous and may vary according to the size and distribution of the blood vessel. Endothelium serves and participates in highly active metabolic and regulatory function including control of primary hemostasis, platelet and leukocyte interaction with the vessel wall. Also, it interacts with the lipoprotein metabolism and presentation of histocompatibility antigens. These dynamic and intricate functions of endothelium are extremely vulnerable which forms the basis for many therapeutic goals to be achieved. A plethora of bioactive molecules have been produced by endothelium. Endothelial factors influence vascular tone, blood flow, clot deposition, clot lysis and selective phagocytic activity. Many protein growth factors, matrix supporting proteins and vasoactive substances have been produced by the endothelium. The functions of vascular endothelium are dynamic rather than fixed. Endothelial derived substances can be mutually antagonistic. Injury to the endothelium causes dysfunction. Immune complexes, lipids, angioplasty, germs, hypertension, shear stress, hypoxia, acidosis, smoking, aging, diabetes mellitus and surgery inflict injury to the endothelium. Endothelial dysfunction is a major cardiovascular factor implicated in the pathogenesis of atherosclerosis, arterial thrombosis, pulmonary hypertension, myocardial infarction, stroke and deep vein thrombosis. New groups of salvaging drugs have been introduced to overcome the consequences of endothelial dysfunction. Yet, the value of existing drug treatment cannot be condoned in conditions of endothelial dysfunction. Time is right to embark on the drugs that modulate endothelial functions to control morbidity and mortality in various cardiovascular diseases. Hopefully, future research will offer us better drugs.

AB - Endothelium is considered as the largest endocrine organ of the human body. The biological functions of endothelium are numerous and may vary according to the size and distribution of the blood vessel. Endothelium serves and participates in highly active metabolic and regulatory function including control of primary hemostasis, platelet and leukocyte interaction with the vessel wall. Also, it interacts with the lipoprotein metabolism and presentation of histocompatibility antigens. These dynamic and intricate functions of endothelium are extremely vulnerable which forms the basis for many therapeutic goals to be achieved. A plethora of bioactive molecules have been produced by endothelium. Endothelial factors influence vascular tone, blood flow, clot deposition, clot lysis and selective phagocytic activity. Many protein growth factors, matrix supporting proteins and vasoactive substances have been produced by the endothelium. The functions of vascular endothelium are dynamic rather than fixed. Endothelial derived substances can be mutually antagonistic. Injury to the endothelium causes dysfunction. Immune complexes, lipids, angioplasty, germs, hypertension, shear stress, hypoxia, acidosis, smoking, aging, diabetes mellitus and surgery inflict injury to the endothelium. Endothelial dysfunction is a major cardiovascular factor implicated in the pathogenesis of atherosclerosis, arterial thrombosis, pulmonary hypertension, myocardial infarction, stroke and deep vein thrombosis. New groups of salvaging drugs have been introduced to overcome the consequences of endothelial dysfunction. Yet, the value of existing drug treatment cannot be condoned in conditions of endothelial dysfunction. Time is right to embark on the drugs that modulate endothelial functions to control morbidity and mortality in various cardiovascular diseases. Hopefully, future research will offer us better drugs.

UR - http://www.scopus.com/inward/record.url?scp=0037384762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037384762&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:0037384762

VL - 35

SP - 73

EP - 82

JO - Indian Journal of Pharmacology

JF - Indian Journal of Pharmacology

SN - 0253-7613

IS - 2

ER -